Compare with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SANOFI INDIA ALKEM LABORATORIES/
SANOFI INDIA
 
P/E (TTM) x - 39.1 - View Chart
P/BV x 6.7 6.9 97.8% View Chart
Dividend Yield % 0.6 1.3 50.8%  

Financials

 ALKEM LABORATORIES   SANOFI INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
SANOFI INDIA
Dec-18
ALKEM LABORATORIES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,5896,840 23.2%   
Low Rs1,2324,630 26.6%   
Sales per share (Unadj.) Rs417.51,203.1 34.7%  
Earnings per share (Unadj.) Rs56.3165.3 34.1%  
Cash flow per share (Unadj.) Rs64.7209.9 30.8%  
Dividends per share (Unadj.) Rs12.7084.00 15.1%  
Dividend yield (eoy) %0.91.5 61.5%  
Book value per share (Unadj.) Rs292.9963.6 30.4%  
Shares outstanding (eoy) m119.5723.03 519.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.8 70.9%   
Avg P/E ratio x25.134.7 72.2%  
P/CF ratio (eoy) x21.827.3 79.8%  
Price / Book Value ratio x4.86.0 80.9%  
Dividend payout %22.650.8 44.4%   
Avg Mkt Cap Rs m168,653132,078 127.7%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m9,1714,068 225.4%   
Avg. sales/employee Rs ThNM8,393.8-  
Avg. wages/employee Rs ThNM1,232.4-  
Avg. net profit/employee Rs ThNM1,153.0-  
INCOME DATA
Net Sales Rs m49,91527,708 180.1%  
Other income Rs m1,645897 183.4%   
Total revenues Rs m51,56128,605 180.2%   
Gross profit Rs m8,4826,235 136.0%  
Depreciation Rs m1,0061,027 97.9%   
Interest Rs m6717 9,580.0%   
Profit before tax Rs m8,4516,098 138.6%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,292 70.1%   
Profit after tax Rs m6,7313,806 176.9%  
Gross profit margin %17.022.5 75.5%  
Effective tax rate %19.037.6 50.6%   
Net profit margin %13.513.7 98.2%  
BALANCE SHEET DATA
Current assets Rs m27,06215,922 170.0%   
Current liabilities Rs m15,3246,235 245.8%   
Net working cap to sales %23.535.0 67.3%  
Current ratio x1.82.6 69.2%  
Inventory Days Days6764 104.5%  
Debtors Days Days4121 197.8%  
Net fixed assets Rs m12,6107,539 167.3%   
Share capital Rs m239230 104.0%   
"Free" reserves Rs m34,49021,962 157.0%   
Net worth Rs m35,02722,192 157.8%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38729,839 182.3%  
Interest coverage x13.6872.1 1.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 98.8%   
Return on assets %13.612.8 106.5%  
Return on equity %19.217.2 112.1%  
Return on capital %24.927.5 90.4%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,5637,587 86.5%   
Fx outflow Rs m3,0127,145 42.2%   
Net fx Rs m3,552442 803.5%   
CASH FLOW
From Operations Rs m7,2593,739 194.1%  
From Investments Rs m1,864-731 -255.0%  
From Financial Activity Rs m-9,273-1,972 470.2%  
Net Cashflow Rs m-1501,036 -14.5%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 33.1 14.4 229.9%  
FIIs % 0.0 14.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 10.5 -  
Shareholders   68,381 15,184 450.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  SUVEN LIFESCIENCES  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 11, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - SUVEN LIFESCIENCES COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS